SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-030018
Filing Date
2009-05-06
Accepted
2009-05-06 16:27:25
Documents
9
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a09-11547_110q.htm 10-Q 1062221
2 EX-10.1 a09-11547_1ex10d1.htm EX-10.1 16261
3 EX-10.2 a09-11547_1ex10d2.htm EX-10.2 74173
4 EX-10.3 a09-11547_1ex10d3.htm EX-10.3 73337
5 EX-31.1 a09-11547_1ex31d1.htm EX-31.1 11993
6 EX-31.2 a09-11547_1ex31d2.htm EX-31.2 12624
7 EX-32.1 a09-11547_1ex32d1.htm EX-32.1 6083
8 EX-32.2 a09-11547_1ex32d2.htm EX-32.2 6233
9 GRAPHIC g115471kii001.jpg GRAPHIC 2415
  Complete submission text file 0001104659-09-030018.txt   1267894
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14732 | Film No.: 09801841
SIC: 2835 In Vitro & In Vivo Diagnostic Substances